003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,990.00
−1.36%Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- KRW 188
- EPS estimate
- KRW 115
- Revenue actual
- KRW 152.2B
- Revenue estimate
- KRW 152.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +63.8%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 7, 2026